サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1536674

認知症治療市場：適応症別、薬剤クラス別、流通経路別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年予測

Dementia Treatment Market, By Indication, By Drug Class, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 322 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.84円
認知症治療市場：適応症別、薬剤クラス別、流通経路別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年予測
出版日: 2024年08月04日
発行: AnalystView Market Insights
ページ情報: 英文 322 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

認知症治療市場規模は2023年に177億9,021万米ドルとなり、2024年から2032年にかけてCAGR 7.80%で拡大

認知症治療市場-市場力学

認知症の市場開拓と研究開発投資の増加が市場需要を促進する見込み

認知症の患者数は特に高齢者の間で増加しており、効果的な治療法やケアソリューションに対する需要が高まっています。認知症の症状に対する認識が高まり、診断ツールが改善されたことで、早期発見・早期治療が可能になり、市場の成長に寄与しています。さらに、研究開発や公衆衛生キャンペーンへの資金提供など、政府やヘルスケア機関からの支援は、技術革新や治療へのアクセスを促進するのに役立っています。このように、認知症の有病率が増加するにつれて、在宅介護、長期介護施設、介護者支援などの支援ケアサービスのニーズが高まっており、市場成長の原動力となっています。

デジタルヘルス・ソリューション、遠隔医療、個別化医療などの医療技術の進歩により、治療の選択肢が増え、患者の管理が向上しています。さらに、製薬会社、バイオテクノロジー企業、ベンチャーキャピタルによる認知症研究と医薬品開発への多額の投資が市場拡大に寄与しています。特に規制当局の承認を受けた新薬や治療法のイントロダクションは、認知症を管理するための利用可能な選択肢を拡大することで、市場の成長に寄与しています。

認知症治療市場-主要インサイト

弊社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約7.80%のCAGRで毎年成長すると予測されています。

適応症のセグメンテーションに基づくと、アルツハイマー病（AD）認知症セグメントは、アルツハイマー病の有病率の増加により、2023年に最大の市場シェアを示すと予測されました。

薬剤クラス別では、ガランタミン、ドネペジルなどの処方率が高いことから、コリンエステラーゼ阻害薬セグメントが2023年に主要な薬剤クラスとなった。

流通チャネル別では、病院での治療ニーズが高いことから、2023年の流通チャネルは病院薬局がトップでした。

地域別では、一流製薬企業や先進医療施設の存在により、北米が2023年の主要収益源でした。

認知症治療市場-セグメンテーション分析：

世界の認知症治療市場は、適応症、薬剤クラス別、流通チャネル別、地域別に区分されます。

市場は適応症に基づいて6つのカテゴリーに分類される：アルツハイマー型認知症、血管性認知症、レビー小体型認知症、前頭側頭型認知症（FTD）、パーキンソン病認知症、その他。アルツハイマー型認知症が市場を独占しています。アルツハイマー病における新治療薬の承認が増加し、セグメントの成長を後押ししています。

市場は薬剤クラス別に、コリンエステラーゼ阻害薬、NMDA受容体拮抗薬、MAO阻害薬、併用薬、その他の5つに分類されます。予測期間中、最も高い成長率を示すと予測されるのは併用薬です。

市場は流通チャネルにより、病院薬局、小売薬局、オンライン薬局の3つに分類されます。病院薬局セグメントは市場を独占しており、予測期間中も高い優位性を維持すると予測されます。オンライン薬局は、ヘルスケアの急速なデジタル化に伴い、予測期間中に最も速い速度で成長すると予測されます。

認知症治療市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。北米が認知症治療市場を独占しています。高齢化により有病率が高いです。米国では、65歳以上の約650万人がアルツハイマー病を患っています。北米は、高度なヘルスケアインフラ、高い医療費、活発な研究開発活動により、世界市場で大きなシェアを占めています。欧州は認知症治療市場の主要市場であり、研究およびヘルスケアサービスに多額の投資を行っています。

認知症治療市場-競合情勢：

認知症治療市場は競争が激しく、数多くの企業が新規薬物療法の開発に取り組んでいます。市場参入企業はアルツハイマー病研究と革新的治療に力を入れています。企業は、個々の患者プロファイルに合わせた治療を行う個別化医療アプローチへの投資を増やしています。学術機関や他の企業との戦略的提携は、研究能力の強化と医薬品開発のスピードアップに注力しています。

目次

第1章 認知症治療市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 認知症治療の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 認知症治療産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 認知症治療市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 認知症治療市場情勢

  • 認知症治療市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 認知症治療市場- 適応症別

  • 概要
    • セグメントシェア分析（適応症別）
    • アルツハイマー病認知症
    • 血管性認知症
    • レビー小体型認知症
    • 前頭側頭型認知症（FTD）
    • パーキンソン病認知症
    • その他

第8章 認知症治療市場-薬剤クラス別

  • 概要
    • 薬剤クラス別セグメントシェア分析
    • コリンエステラーゼ阻害剤
    • NMDA受容体拮抗薬
    • MAO阻害剤
    • 併用薬
    • その他

第9章 認知症治療市場- 流通チャネル別

  • 概要
    • 流通チャネル別セグメントシェア分析
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第10章 認知症治療市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 認知症治療業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Eli Lilly and Company
    • Biogen Inc.
    • Roche Holding AG
    • Novartis International AG
    • Johnson &Johnson
    • AstraZeneca PLC
    • Amylyx Pharmaceuticals
    • Cassava Sciences, Inc.
    • Lundbeck A/S
    • Otsuka Pharmaceutical Co., Ltd.
    • Sanofi SA
    • Pfizer Inc.
    • Merck &Co., Inc.
    • Takeda Pharmaceutical Company Limited
    • Eisai Co., Ltd.
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Dementia Treatment Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Dementia Treatment Market, by Indication 2019-2032 (USD Million)
  • TABLE Dementia Treatment Market: Drug Class Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Dementia Treatment Market, by Drug Class 2019-2032 (USD Million)
  • TABLE Dementia Treatment Market: Distribution Channel Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Dementia Treatment Market, by Distribution Channel 2019-2032 (USD Million)
  • TABLE Dementia Treatment Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Dementia Treatment Market, by Region 2019-2032 (USD Million)
  • TABLE North America Dementia Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Dementia Treatment Market, by Indication, 2019-2032 (USD Million)
  • TABLE North America Dementia Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE North America Dementia Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Europe Dementia Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Dementia Treatment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Dementia Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Europe Dementia Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Asia Pacific Dementia Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Dementia Treatment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Dementia Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Asia Pacific Dementia Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Latin America Dementia Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Dementia Treatment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Dementia Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Latin America Dementia Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Dementia Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Dementia Treatment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Dementia Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Dementia Treatment Market, by Distribution Channel, 2019-2032 (USD Million)

List of Figures

  • FIGURE Dementia Treatment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Indication segment market share analysis, 2023 & 2032
  • FIGURE Indication segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Drug Class segment market share analysis, 2023 & 2032
  • FIGURE Drug Class segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2023 & 2032
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Dementia Treatment Market share and leading players, 2023
  • FIGURE Europe Dementia Treatment Market share and leading players, 2023
  • FIGURE Asia Pacific Dementia Treatment Market share and leading players, 2023
  • FIGURE Latin America Dementia Treatment Market share and leading players, 2023
  • FIGURE Middle East and Africa Dementia Treatment Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Dementia Treatment Market share analysis by country, 2023
  • FIGURE Germany Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Dementia Treatment Market share analysis by country, 2023
  • FIGURE India Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Dementia Treatment Market share analysis by country, 2023
  • FIGURE Brazil Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Dementia Treatment Market share analysis by country, 2023
  • FIGURE Saudi Arabia Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3523

REPORT HIGHLIGHT

Dementia Treatment Market size was valued at USD 17,790.21 Million in 2023, expanding at a CAGR of 7.80% from 2024 to 2032.

Dementia treatment focuses on managing symptoms, improving quality of life, and slowing the progression of the disease. Dementia treatment plans are often tailored to the individual and may require adjustments over time as the disease progresses.

Dementia Treatment Market- Market Dynamics

Growing prevalence of dementia and increased investment in research & development are expected to propel market demand

The number of individuals affected by dementia is increasing especially among older adults, which fuels demand for effective treatments and care solutions. Greater awareness of dementia symptoms and improved diagnostic tools lead to earlier detection and treatment, contributing to market growth. Further, support from governments and healthcare organizations, including funding for research and development and public health campaigns, helps drive innovation and access to treatments. Thus, As the prevalence of dementia increases, there is a growing need for supportive care services, including home care, long-term care facilities, and caregiver support, driving market growth.

Advances in medical technology, such as digital health solutions, telemedicine, and personalized medicine, are enhancing treatment options and improving patient management. Additionally, Significant investments from pharmaceutical companies, biotech firms, and venture capitalists into dementia research and drug development contribute to the expansion of the market. The introduction of new drugs and treatments, particularly those receiving regulatory approval, contributes to market growth by expanding available options for managing dementia.

Dementia Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.80% over the forecast period (2024-2032)

Based on Indication segmentation, the Alzheimer's disease (AD) dementia segment was predicted to show maximum market share in the year 2023, owing to the increased prevalence if Alzheimer's disease.

Based on Drug Class segmentation, the cholinesterase inhibitors segment was the leading drug class in 2023, due to high prescription rates of galantamine, donepezil, etc.

Based on Distribution Channel segmentation, the hospital pharmacy segment was the leading Distribution Channel in 2023, owing to the high need for hospital treatment.

On the basis of region, North America was the leading revenue generator in 2023, owing to presence of top pharmaceutical companies & advanced medical facilities.

Dementia Treatment Market- Segmentation Analysis:

The Global Dementia Treatment Market is segmented on the basis of Indication, Drug Class, Distribution Channel, and Region.

The market is divided into six categories based on Indication: Alzheimer's Disease Dementia, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia (FTD), Parkinson's Disease Dementia, and others. The Alzheimer's Disease Dementia segment dominates the market. With the increasing approval of new therapeutics drugs in Alzheimer's boosting segment growth.

The market is divided into five categories based on Drug Class: cholinesterase inhibitors, NMDA receptor antagonists, MAO inhibitors, combination drugs, and others. The combination drugs segment is projected to grow at the highest rate over the forecast period.

The market is divided into three categories based on Distribution channels: hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment dominates the market and is expected to maintain its high dominance during the forecast period. Online pharmacy is anticipated to grow at the fastest rate during the forecast period with the rapid digitalization in healthcare.

Dementia Treatment Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the Dementia Treatment market. High prevalence due to aging populations. In the U.S., nearly 6.5 million people aged 65 and older are living with Alzheimer's disease. North America holds a significant share of the global market due to advanced healthcare infrastructure, high healthcare expenditure, and robust research and development activities. Europe is a key market in the dementia treatment market with considerable investments in research and healthcare services.

Dementia Treatment Market- Competitive Landscape:

The dementia treatment market is highly competitive, with numerous companies involved in developing and novel drug therapies. Market players have a strong emphasis on Alzheimer's research and innovative treatments. Companies are increasingly investing in personalized medicine approaches to tailor treatments to individual patient profiles. Strategic alliances with academic institutions and other companies are focusing on enhancing research capabilities and speeding up drug development.

Recent Developments:

In January 2024, Eisai Co., Ltd. and Biogen got approval for Leqembi for the treatment of mild cognitive impairment due to AD dementia.

In May 2023, Eli Lilly stated the positive results of a phase-3 clinical study demonstrated that donanemab significantly slowed cognitive and functional decline in Alzheimer's disease.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DEMENTIA TREATMENT MARKET KEY PLAYERS

  • Eli Lilly and Company
  • Biogen Inc.
  • Roche Holding AG
  • Novartis International AG
  • Johnson & Johnson
  • AstraZeneca PLC
  • Amylyx Pharmaceuticals
  • Cassava Sciences, Inc.
  • Lundbeck A/S
  • Otsuka Pharmaceutical Co., Ltd.
  • Sanofi S.A.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Takeda Pharmaceutical Company Limited
  • Eisai Co., Ltd.
  • Others

GLOBAL DEMENTIA TREATMENT MARKET, BY INDICATION- MARKET ANALYSIS, 2019-2032

  • Alzheimer's Disease Dementia
  • Vascular Dementia
  • Lewy Body Dementia
  • Frontotemporal Dementia (FTD)
  • Parkinson Disease Dementia
  • Others

GLOBAL DEMENTIA TREATMENT MARKET, BY DRUG CLASS- MARKET ANALYSIS, 2019-2032

  • Cholinesterase Inhibitors
  • NMDA Receptor Antagonist
  • MAO Inhibitors
  • Combination Drug
  • Others

GLOBAL DEMENTIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019-2032

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

GLOBAL DEMENTIA TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Dementia Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Dementia Treatment Market Snippet by Indication
    • 2.1.2. Dementia Treatment Market Snippet by Drug Class
    • 2.1.3. Dementia Treatment Market Snippet by Distribution Channel
    • 2.1.4. Dementia Treatment Market Snippet by Country
    • 2.1.5. Dementia Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Dementia Treatment Key Market Trends

  • 3.1. Dementia Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Dementia Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Dementia Treatment Market Opportunities
  • 3.4. Dementia Treatment Market Future Trends

4. Dementia Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Dementia Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Dementia Treatment Market Landscape

  • 6.1. Dementia Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Dementia Treatment Market - By Indication

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
    • 7.1.2. Alzheimer's Disease Dementia
    • 7.1.3. Vascular Dementia
    • 7.1.4. Lewy Body Dementia
    • 7.1.5. Frontotemporal Dementia (FTD)
    • 7.1.6. Parkinson Disease Dementia
    • 7.1.7. Others

8. Dementia Treatment Market - By Drug Class

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Drug Class, 2024 & 2032 (%)
    • 8.1.2. Cholinesterase Inhibitors
    • 8.1.3. NMDA Receptor Antagonist
    • 8.1.4. MAO Inhibitors
    • 8.1.5. Combination Drug
    • 8.1.6. Others

9. Dementia Treatment Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2024 & 2032 (%)
    • 9.1.2. Hospital Pharmacy
    • 9.1.3. Retail Pharmacy
    • 9.1.4. Online Pharmacy

10. Dementia Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Dementia Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Dementia Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Dementia Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Dementia Treatment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Dementia Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Dementia Treatment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Eli Lilly and Company
    • 11.2.2. Biogen Inc.
    • 11.2.3. Roche Holding AG
    • 11.2.4. Novartis International AG
    • 11.2.5. Johnson & Johnson
    • 11.2.6. AstraZeneca PLC
    • 11.2.7. Amylyx Pharmaceuticals
    • 11.2.8. Cassava Sciences, Inc.
    • 11.2.9. Lundbeck A/S
    • 11.2.10. Otsuka Pharmaceutical Co., Ltd.
    • 11.2.11. Sanofi S.A.
    • 11.2.12. Pfizer Inc.
    • 11.2.13. Merck & Co., Inc.
    • 11.2.14. Takeda Pharmaceutical Company Limited
    • 11.2.15. Eisai Co., Ltd.
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us